Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Assets Average (2014 - 2026)

Scynexis' (SCYX) quarterly Assets Average came in at $76.3 million in Q2 2026, up 18.65% on a YoY basis from $64.3 million in Q2 2025, and up 11.67% quarter-over-quarter from $68.3 million in Q1 2026.

Analysis

Scynexis (SCYX) Assets Average (2014 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Assets Average for 13 consecutive years, with $76.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Assets Average rose 18.65% year-over-year to $76.3 million; the trailing twelve-month figure through Jun 2026 stood at $76.3 million (up 18.65% YoY), and the FY2025 full-year result was $74.8 million, down 31.67% from the prior year.
  • Assets Average improved to $76.3 million in Q2 2026 per SCYX's latest filing, from $68.3 million in the prior quarter.
  • Across five years, Assets Average topped out at $151.7 million in Q3 2023 and bottomed at $55.0 million in Q4 2025.
  • Historically, Assets Average has averaged $98.8 million across 5 years, with a median of $101.7 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Assets Average soared 56.01% in 2024, then tumbled 45.97% in 2025.
  • Over 5 years, Assets Average stood at $100.1 million in 2022, then jumped by 38.41% to $138.5 million in 2023, then tumbled by 31.51% to $94.8 million in 2024, then tumbled by 41.96% to $55.0 million in 2025, then jumped by 38.6% to $76.3 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $76.3 million, $68.3 million, and $55.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 94.07 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 52.82 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 26.95 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 41.30 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 11.22 Bn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 5.34 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 30.78 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 5.51 Bn
10 Scynexis 58.41 Mn -56.29 Mn - 76.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 76.30 Mn
Mar 31, 2026 68.33 Mn
Dec 31, 2025 55.05 Mn
Sep 30, 2025 55.88 Mn
Jun 30, 2025 64.30 Mn
Mar 31, 2025 79.28 Mn
Dec 31, 2024 94.84 Mn
Sep 30, 2024 103.42 Mn
Jun 30, 2024 113.03 Mn
Mar 31, 2024 123.33 Mn
Dec 31, 2023 138.48 Mn
Sep 30, 2023 151.70 Mn
Jun 30, 2023 112.58 Mn
Mar 31, 2023 79.05 Mn
Dec 31, 2022 100.05 Mn
Sep 30, 2022 123.95 Mn
Jun 30, 2022 123.59 Mn
Mar 31, 2022 115.70 Mn
Dec 31, 2021 114.86 Mn
Sep 30, 2021 115.51 Mn